clofenac injection
square pharmaceuticals plc, gazipur - diclofenac sodium - injection - 75 mg/3 ml
teva-diclofenac suppository
teva canada limited - diclofenac sodium - suppository - 100mg - diclofenac sodium 100mg - other nonsteroidal antiimflammatory agents
teva-diclofenac suppository
teva canada limited - diclofenac sodium - suppository - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents
ntp-diclofenac sodium tablet (enteric-coated)
teva canada limited - diclofenac sodium - tablet (enteric-coated) - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents
ntp-diclofenac sodium sr tablet (extended-release)
teva canada limited - diclofenac sodium - tablet (extended-release) - 75mg - diclofenac sodium 75mg - other nonsteroidal antiimflammatory agents
diclax sr
douglas pharmaceuticals limited - diclofenac sodium 100mg; ; - modified release tablet - 100 mg - active: diclofenac sodium 100mg excipient: diethyl phthalate ethylcellulose hypromellose iron oxide red iron oxide yellow macrogol 4000 magnesium stearate povidone purified talc stearic acid titanium dioxide
diclax sr
douglas pharmaceuticals limited - diclofenac sodium 75mg; ; - modified release tablet - 75 mg - active: diclofenac sodium 75mg excipient: diethyl phthalate ethylcellulose hypromellose iron oxide red iron oxide yellow macrogol 4000 magnesium stearate povidone purified talc stearic acid titanium dioxide
diclofenac sodium gel
ipg pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. diclofenac sodium gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
diclofenac sodium gel
actavis pharma, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium topical gel is indicated for the topical treatment of actinic keratosis (ak). diclofenac sodium topical gel is contraindicated in the following patients: - with known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see warnings and precautions (5.1, 5.3, 5.10) and description (11)] - with the history of asthma, urticaria, or other allergic type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.1, 5.2)] - application on damaged skin resulting from any etiology, including exudative dermatitis, eczema, infected lesions, burns or wounds [see warnings and precautions (5.3)] - in the setting of coronary bypass graft (cabg) surgery [see warnings and precautions (5.4)] risk summary use of nsaids, including diclofenac sodium can cause premature closure of the fetal ductus arteriosus and fetal ren
diclofenac sodium gel
pharmaceutica north america, inc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium.